Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 16Breast 5Thoracic 4Other hematologic neoplasm 3Lymphoid 3Plasma cell 2Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Testicular Neoplasms 1Hypogonadism 1

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 163Specimen Handling 135enzalutamide 126Nivolumab 124Gemcitabine 99Docetaxel 96Radiosurgery 92Prednisone 85Androgen Antagonists 82Abiraterone Acetate 81Radiotherapy 75apalutamide 68Cisplatin 65darolutamide 63Ipilimumab 63Biopsy 60abiraterone 58Carboplatin 56cabozantinib 55Leuprolide 53enfortumab vedotin 49Radiation 48Pluvicto 45Standard of Care 44atezolizumab 40Surveys and Questionnaires 39acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mental Status and Dementia Tests × Genitourinary × 1 year × Clear all
NCT06191575 2025-12-22

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

University of Southern California

Suspended
10 enrolled
Genitourinary

Hypogonadism, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡